| Karl Torgerson, PA | |
|
223 S 200 E, Enterprise, UT 84725 | |
| (435) 878-2281 | |
| Not Available |
| Full Name | Karl Torgerson |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 223 S 200 E, Enterprise, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417253824 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 6309362-1206 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karl Torgerson, PA Po Box 370, Enterprise, UT 84725-0370 Ph: (435) 878-2281 | Karl Torgerson, PA 223 S 200 E, Enterprise, UT 84725 Ph: (435) 878-2281 |
News Archive
Physicians might one day be able to treat a disease that destroys brain cells in children using genetically modified cells to transport a "drug" to the site of the dying neural cells (cells that transmit impulses).
In four separate studies of mothers and their infants, preschoolers, kids and teens, a multi-university research team has shown, for the first time, that a simple test of a little drool can provide new insight into the role of social stressors, including relationships with parents and teachers, in child development.
Corticosteroid drugs that are given by inhalers to children with asthma may suppress their growth, evidence suggests. Two new systematic reviews published in The Cochrane Library focus on the effects of inhaled corticosteroid drugs (ICS) on growth rates.
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.
Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 7 days ago
Zachary Douglas Fisher, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 257 S 625 E, Enterprise, UT 84725 Phone: 435-669-6168 |